BioCentury | Oct 5, 2015
Emerging Company Profile

Picking a PCSK9

As the first mAbs against PCSK9 are making their market debuts, several companies are vying to replace them with oral candidates. Liphorus Pharmaceuticals Inc. has assembled a test kitchen of screens for small molecules with...
BioCentury | Sep 1, 2014

Nurturing killer seeds

Index Ventures is not the first VC to operate an incubator that conducts killer experiments on seed projects. But what could set the "Index Nursery" apart is the firm's intention to publicize its failures along...
Items per page:
1 - 2 of 2